Home / France / Phaxiam Therapeutics
Phaxiam Therapeutics
No short position is open on this share today.
Evolution of the disclosed total
March 31, 2015 today
Open positions
No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Get the moves on Phaxiam Therapeutics by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| October 26, 2015 | GSA Capital Partners LLP | 1.60% | August 8, 2016 |
| October 23, 2015 | GSA Capital Partners LLP | 1.59% | August 8, 2016 |
| October 22, 2015 | GSA Capital Partners LLP | 1.60% | August 8, 2016 |
| October 12, 2015 | GSA Capital Partners LLP | 1.50% | August 8, 2016 |
| September 24, 2015 | GSA Capital Partners LLP | 1.40% | August 8, 2016 |
| August 21, 2015 | GSA Capital Partners LLP | 1.30% | August 8, 2016 |
| July 27, 2015 | GSA Capital Partners LLP | 1.20% | August 8, 2016 |
| June 22, 2015 | GSA Capital Partners LLP | 1.10% | August 8, 2016 |
| June 18, 2015 | GSA Capital Partners LLP | 1.09% | August 8, 2016 |
| June 16, 2015 | GSA Capital Partners LLP | 1.10% | August 8, 2016 |
| May 26, 2015 | GSA Capital Partners LLP | 1.00% | August 8, 2016 |
| May 19, 2015 | GSA Capital Partners LLP | 0.92% | August 8, 2016 |
| May 11, 2015 | GSA Capital Partners LLP | 0.81% | August 8, 2016 |
| April 27, 2015 | GSA Capital Partners LLP | 0.70% | August 8, 2016 |
| April 7, 2015 | GSA Capital Partners LLP | 0.61% | August 8, 2016 |
| March 31, 2015 | GSA Capital Partners LLP | 0.54% | August 8, 2016 |
Download 66 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Valeo 12.22% of the capital sold short
- Renault 11.13% of the capital sold short
- Ubisoft Entertainment 10.74% of the capital sold short
- Viridien 10.50% of the capital sold short
- FDJ United 6.73% of the capital sold short
- Alstom 6.39% of the capital sold short
- Abivax 5.59% of the capital sold short
- Teleperformance 5.32% of the capital sold short
- Gaztransport et Technigaz 4.72% of the capital sold short
- Forvia 4.38% of the capital sold short
- Rémy Cointreau 4.25% of the capital sold short
- Atos Group 3.79% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Phaxiam Therapeutics, source AMF, data as at December 16, 2021, https://www.quivad.com/action/phaxiam-therapeutics?page=2